Display Settings:

Format

Send to:

Choose Destination
J Magn Reson Imaging. 2010 Sep;32(3):502-15. doi: 10.1002/jmri.22266.

Imaging biomarkers of cardiovascular disease.

Author information

  • 1Department of Radiology, University of Washington, Seattle, Washington, USA.

Abstract

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. Current clinical techniques that rely on stenosis measurement alone appear to be insufficient for risk prediction in atherosclerosis patients. Many novel imaging methods have been developed to study atherosclerosis progression and to identify new features that can predict future clinical risk. MRI of atherosclerotic vessel walls is one such method. It has the ability to noninvasively evaluate multiple biomarkers of the disease such as luminal stenosis, plaque burden, tissue composition and plaque activity. In addition, the accuracy of in vivo MRI has been validated against histology with high reproducibility, thus paving the way for application to epidemiological studies of disease pathogenesis and, by serial MRI, in monitoring the efficacy of therapeutic intervention. In this review, we describe the various MR techniques used to evaluate aspects of plaque progression, discuss imaging-based measurements (imaging biomarkers), and also detail their validation. The application of plaque MRI in clinical trials as well as emerging imaging techniques used to evaluate plaque compositional features and biological activities are also discussed.

PMID:
20815049
[PubMed - indexed for MEDLINE]
PMCID:
PMC2935309
Free PMC Article

Images from this publication.See all images (6)Free text

Fig.1
Fig.2
Fig.3
Fig.4
Fig.5
Fig.6
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc. Icon for PubMed Central
    Loading ...
    Write to the Help Desk